Search Results - "Lorefice, E"

Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C by Arena, U, Vizzutti, F, Abraldes, J G, Corti, G, Stasi, C, Moscarella, S, Milani, S, Lorefice, E, Petrarca, A, Romanelli, R G, Laffi, G, Bosch, J, Marra, F, Pinzani, M

“…Transient elastography (TE) has received increasing attention as a means to evaluate disease progression in patients with chronic liver disease. To assess the…”
Get more information

Does the Bayley‐III Motor Scale at 2 years predict motor outcome at 4 years in very preterm children? by Spittle, Alicia J, Spencer‐Smith, Megan M, Eeles, Abbey L, Lee, Katherine J, Lorefice, Lucy E, Anderson, Peter J, Doyle, Lex W

“…Aim To assess the predictive validity of the Bayley Scales of Infant and Toddler Development – Third Edition (Bayley‐III) for later motor outcome. Method…”
Get full text

Accuracy of Two Motor Assessments during the First Year of Life in Preterm Infants for Predicting Motor Outcome at Preschool Age by Spittle, Alicia J, Lee, Katherine J, Spencer-Smith, Megan, Lorefice, Lucy E, Anderson, Peter J, Doyle, Lex W

“…The primary aim of this study was to investigate the accuracy of the Alberta Infant Motor Scale (AIMS) and Neuro-Sensory Motor Developmental Assessment (NSMDA)…”
Get full text

Cervicodorsal extramedullary anaplastic ependymoma with intracranial metastasis by Marco Del Pont, F., Villamil, F., Lorefice, E., Caffaratti, G., Centeno, T.R., Ruella, M., Mormandi, R.

Get full text

PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C. PROSPECTIVE ANALYSIS OF REPEAT LIVER BIOPSIES by Caciolli, L, Lorefice, E, Milani, S, Surrenti, C

Get full text

P.17.18 ACCEPT AND DIAGNOSTIC ABILITY OF COLONOSCOPY IN COLORECTAL CANCER SCREENING IN EMPOLESE DISTRICT OF ASL-11 by Calella, F, Lorefice, E, Trappoliere, M, Solipano, F, Tani, S, Carloppi, S, Pignalosa, P, Belli, F, Tarantino, O, Casalini, D, Biagini, M

Get full text

P.1.278: METABOLOMIC ANALYSIS FOR NON INVASIVE DIAGNOSIS OF ADVANCED FIBROSIS AND EARLY CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS C by Gabbani, T, Calabrò, A, Lorefice, E, Giannotta, M, Bernini, P, Grappone, C, Marsico, M, Milani, S

Get full text

P.131 VIRAL KINETICS IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH COMBINATION THERAPY WITH PEG-IFN AND NUCLEOSIDE ANALOGUES by Lorefice, E, Bucciero, F, Forte, P, Elena, G, Stasi, C, Zignego, A, Giannini, C, Farese, A, Bresci, S, Puntili, R, Corti, G, Milani, S, Surrenti, C

Get full text

ROLE OF DNA ANEUPLOIDY IN COLORECTAL CANCER SURVEILLANCE IN PATIENTS WITH LONG-STANDING ULCERATIVE COLITIS by Giannotta, M, Bagnoli, S, Messerini, L, Caldini, A, Genise, S, Balzi, M, Lorefice, E, Milani, S, Milla, M

Get full text

Postural control at 4 years in very preterm children compared with term‐born peers by Lorefice, Lucy E, Galea, Mary P, Clark, Ross A, Doyle, Lex W, Anderson, Peter J, Spittle, Alicia J

“…Aim To compare postural control at 4 years' corrected age in very preterm children (VPT; <30wks gestational age) with term‐born (>37wks gestational age)…”
Get full text

762 TRANSIENT ELASTOGRAPHY (TE) IS MORE EFFECTIVE FOR THE IDENTIFICATION OF HCV PATIENTS WITH ADVANCED (F3-F4) RATHER THAN SIGNIFICANT (F2-F4) LIVER FIBROSIS by Arena, U, Vizzutti, F, Abraldes, J.G, Corti, G, Stasi, C, Moscarella, S, Milani, S, Lorefice, E, Petrarca, A, Laffi, G, Bosch, J, Marra, F, Pinzani, M

Get full text

PA.104 PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN by Paci, M, Lorefice, E, Gianni, E, Renzo, S, Capanni, M, Forte, P, Milani, S, Surrenti, C

Get full text

OC3.10.4 ASSESSMENT OF BONE MINERAL DENSITY IN PRIMARY BILIARY CIRROSIS AND CHRONIC HEPATITIS C by Lorefice, E, Boccadori, C, Tozzi, A, Paci, M, Capanni, M, Biagini, M.R, Milani, S, Surrenti, C

Get full text

Transient elastography (TE) is more effective for the identification of HCV patients with severe (≥F3) rather than significant (≥F2) liver fibrosis by Arena, U, Vizzutti, F, Abraldes, J.G, Corti, G, Stasi, C, Moscarella, S, Milani, S, Lorefice, E, Petrarca, A, Laffi, G, Marra, F, Pinzani, M

Get full text

Occurrence of Diffuse, Poorly Differentiated Hepatocellular Carcinoma During Pegylated Interferon Plus Ribavirin Combination Therapy for Chronic Hepatitis C by CAPANNI, M, LOREFICE, E, BENINI, M. C, BIAGINI, M. R, TOZZI, A, SALVADORI, E, COLAGRANDE, S, SURRENTI, C, MILANI, S

“…Interferon therapy is indicated for the treatment of chronic hepatitis C and prevention of hepatocellular carcinoma. We describe the case of a 66-year-old…”
Get full text

Occurrence of tuberculous spondylitis after peg-interferon alfa-2b plus ribavirin combination therapy for chronic hepatitis C by Capanni, M., Lorefice, E., Biagini, M.R., Benini, M.C., Tozzi, A., Galli, A., Surrenti, C., Milani, S.

Get full text

Detection of hepatocellular carcinoma during the treatment with pegylated interferon alfa-2a and ribavirin for chronic hepatitis C by Capanni, M., Lorefice, E., Benini, M.C., Biagini, M.R., Tozzi, A., Galli, A., Surrenti, C., Milani, S.

Get full text

Comparison between combination therapy with peg-interferon alfa-2A plus ribavirin and peg-interferon alfa-2B plus ribavirin in the treatment of chronic hepatitis C by Capanni, M., Biagini, M.R., Nanni, S., Lorefice, E., Paci, M., Benini, M.C., Gai, E., Tozzi, A., Galli, A., Surrenti, C., Milani, S.

Get full text

Does the B ayley‐ III M otor S cale at 2 years predict motor outcome at 4 years in very preterm children? by Spittle, Alicia J, Spencer‐Smith, Megan M, Eeles, Abbey L, Lee, Katherine J, Lorefice, Lucy E, Anderson, Peter J, Doyle, Lex W

“…Aim To assess the predictive validity of the Bayley Scales of Infant and Toddler Development – Third Edition ( B ayley‐ III ) for later motor outcome. Method…”
Get full text

Occurrence of Diffuse, Poorly Differentiated Hepatocellular Carcinoma During Pegylated Interferon Plus Ribavirin Combination Therapy for Chronic Hepatitis C by Capanni, M., Lorefice, E., Benini, M.C., Biagini, M.R., Tozzi, A., Salvadori, E., Colagrande, S., Surrenti, C., Milani, S.

“…Interferon therapy is indicated for the treatment of chronic hepatitis C and prevention of hepatocellular carcinoma. We describe the case of a 66-year-old…”
Get full text